|
Latest Communications |
|
APR IS engaged in the research, development, and licensing of added value, technology driven and clinically proven prescription pharmaceuticals.
The innovative business approach based on an integrated vision of technologies available and market opportunities
enables APR to select and in-license innovation opportunities or develop internally the whole cycle of research&development
bringing to fruition innovative product deliveries to improve patients quality of life.
APR files and obtains worldwide market approval and sells them through an established network of commercial partners globally.